Clinical Trials in Tennessee

Showing 14421-14440 of 20,239 trials

Evaluation of the Ulthera System for the Treatment of the Decolletage

NCT01713686

This is prospective, multi-center clinical trial. Enrolled subjects will receive one Ulthera® treatment on the decolletage. Follow-up visits will occur at 90 and 180 days following treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Chest Wrinkles

Ulthera, Inc129 participantsStarted Oct 2012

Sacramento, California, United States • San Diego, California, United States • Chicago, Illinois, United States +1 more locations

COMPLETEDPhase 229 miles

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

NCT00726323

This clinical study is being conducted at multiple sites to determine the best confirmed response rate, safety, and tolerability of GSK1363089 treatment in papillary renal cell carcinoma. Papillary renal cell carcinoma may be classified into hereditary and sporadic forms; subjects with either classification will be accepted into this study.

Carcinoma, Renal Cell

GlaxoSmithKline74 participantsStarted Jun 2006

Greenbrae, California, United States • San Francisco, California, United States • Stanford, California, United States +9 more locations

Evaluation of the Ulthera System for the Treatment of the Decolletage

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Find Trials by Condition in Tennessee

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

LifeVest Post-CABG Registry

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Comparison of Cervical Laminectomy to Laminoplasty

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

International PFO Consortium